Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Agent of Impact Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe Log In

LeapFrog leads $55 million investment in MedGenome to expand genetic testing

ImpactAlpha, April 1 – The Indian subcontinent makes up about 20% of the world’s population, but only 0.2% of the DNA sequences in global genetic databases.

Bangalore-based MedGenome is expanding early disease risk detection, inherited disease prevention and health care personalization to India’s smaller cities and other emerging markets, “where the burden of many inherited and complex diseases is even higher than in western markets,” says MedGenome’s Sam Santhosh.

Emerging markets-focused impact investors LeapFrog has led a $55 million funding round for the company. Existing investors Sofina and Sequoia also participated.

“Genomic sequencing will anchor the future of medicine and we must include other underrepresented genomes not only because it drives access, but also because it improves the accuracy for everyone,” says LeapFrog’s Felix Olale.

LeapFrog last year closed a $700 million fund for healthcare and financial services.


You might also like...